CASABIANCA, ANNA
 Distribuzione geografica
Continente #
NA - Nord America 9.530
EU - Europa 5.547
AS - Asia 3.091
SA - Sud America 299
AF - Africa 57
OC - Oceania 20
Continente sconosciuto - Info sul continente non disponibili 11
Totale 18.555
Nazione #
US - Stati Uniti d'America 9.451
GB - Regno Unito 2.234
CN - Cina 1.672
SG - Singapore 787
UA - Ucraina 765
IT - Italia 710
SE - Svezia 413
RU - Federazione Russa 342
FI - Finlandia 314
TR - Turchia 296
DE - Germania 281
BR - Brasile 242
IE - Irlanda 178
FR - Francia 161
VN - Vietnam 100
JP - Giappone 87
CA - Canada 52
IN - India 44
PL - Polonia 33
BE - Belgio 32
MA - Marocco 25
AR - Argentina 19
KR - Corea 18
AU - Australia 17
MX - Messico 17
ZA - Sudafrica 17
ES - Italia 16
BD - Bangladesh 13
NL - Olanda 13
IR - Iran 12
DK - Danimarca 11
EC - Ecuador 11
EU - Europa 10
CL - Cile 9
PY - Paraguay 9
LT - Lituania 8
HK - Hong Kong 7
SA - Arabia Saudita 7
CH - Svizzera 6
IQ - Iraq 6
AE - Emirati Arabi Uniti 5
AT - Austria 5
JO - Giordania 5
ID - Indonesia 4
KZ - Kazakistan 4
MY - Malesia 4
PT - Portogallo 4
TG - Togo 4
UZ - Uzbekistan 4
AZ - Azerbaigian 3
CO - Colombia 3
EG - Egitto 3
LA - Repubblica Popolare Democratica del Laos 3
LV - Lettonia 3
NO - Norvegia 3
NZ - Nuova Zelanda 3
PA - Panama 3
AM - Armenia 2
BG - Bulgaria 2
CI - Costa d'Avorio 2
EE - Estonia 2
ET - Etiopia 2
GR - Grecia 2
HR - Croazia 2
JM - Giamaica 2
MD - Moldavia 2
PE - Perù 2
PH - Filippine 2
PK - Pakistan 2
RO - Romania 2
UY - Uruguay 2
VE - Venezuela 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AL - Albania 1
CM - Camerun 1
CR - Costa Rica 1
DZ - Algeria 1
GD - Grenada 1
GT - Guatemala 1
HN - Honduras 1
HU - Ungheria 1
IL - Israele 1
KE - Kenya 1
KG - Kirghizistan 1
KH - Cambogia 1
LK - Sri Lanka 1
NG - Nigeria 1
PR - Porto Rico 1
RS - Serbia 1
Totale 18.555
Città #
Southend 2.069
Fairfield 1.140
Woodbridge 981
Ann Arbor 891
Houston 879
Ashburn 840
Jacksonville 615
Chandler 486
Seattle 461
Cambridge 440
Dallas 414
Wilmington 388
Nanjing 332
Singapore 314
Beijing 241
Urbino 223
Izmir 222
Boardman 170
Dublin 168
New York 144
Nanchang 137
Helsinki 133
Moscow 108
Los Angeles 105
San Mateo 96
Princeton 95
Tianjin 82
Shenyang 74
Düsseldorf 68
Changsha 56
Hebei 56
Istanbul 55
Jiaxing 43
Munich 42
Bremen 41
Ho Chi Minh City 39
London 38
San Diego 36
Buffalo 35
Kunming 35
Brussels 28
Jinan 28
Velikiy Novgorod 27
San Francisco 26
Shanghai 26
Toronto 26
Hangzhou 25
São Paulo 25
Santa Clara 22
Casablanca 21
Frankfurt am Main 21
Orem 20
Guangzhou 19
Turku 19
Chicago 18
Hanoi 18
Seongnam 18
Tokyo 17
Cagli 16
Warsaw 16
Zhengzhou 16
Denver 15
Lanzhou 14
Napoli 13
Rome 13
Stockholm 13
Des Moines 12
Johannesburg 12
Leawood 12
Mülheim 12
Taizhou 12
The Dalles 12
Boston 11
Brooklyn 11
Changchun 11
Council Bluffs 11
Kraków 11
Milan 11
Ningbo 11
Atlanta 10
Auburn Hills 10
Fano 10
Manchester 10
Montreal 10
Augusta 9
Falls Church 9
Rio de Janeiro 9
Venice 9
Xi'an 9
Chennai 8
Lauterbourg 8
Mumbai 8
Orange 8
Redwood City 8
Ardabil 7
Curitiba 7
Hong Kong 7
Norwalk 7
Osimo 7
Querétaro 7
Totale 13.638
Nome #
Switching to elvitegravir/cobicistat/emtricitabine/tenofovir disoproxil fumarate single-tablet regimen (Stribild†): effects on T-cell compartment and HIV reservoirs 491
Glutathione Depletion Is Linked with Th2 Polarization in Mice with a Retrovirus-Induced Immunodeficiency Syndrome, Murine AIDS: Role of Proglutathione Molecules as Immunotherapeutics 401
Effect of starvation on survival and virulence expression of Aeromonas hydrophila from different sources 340
Antiviral and Immunomodulatory Properties of New Pro-Glutathione (GSH) Molecules. 285
A Real Time PCR Platform for the Simultaneous Quantification of Total and Extrachromosomal HIV DNA Forms in Blood of HIV-1 Infected Patients 278
A recombinant human 'mini'-hexokinase is catalytically active and regulated by hexose 6-phosphates 267
Inhibition of murine AIDS by pro-glutathione (GSH) molecules 262
A new one-step RT-PCR method for virus quantitation in murine AIDS. 262
2',3'-Dideoxycytidine metabolism in a new drug-resistant cell line 260
2',3'-Dideoxycytidine induced drug resistance in human cells 254
Erythrocytes as carriers of antisense PNA addressed against HIV-1 gag-pol transframe domain 251
Pharmacokinetic and antiretroviral activity in mice of oral [P(1),P(2)-bis[2-(adenin-9-yl)ethoxymethyl]phosphonate], a prodrug of 9-(2-phosphonylmethoxyethyl)adenine 251
Molecules Altering the Intracellular Thiol Content Modulate NF-kB and STAT-1/IRF-1 Signalling Pathways and IL-12 p40 and IL-27 p28 Production in Murine Macrophages 250
2\',3\'-Dideoxycytidine cytotoxicity in human macrophages. 249
Development of a real time PCR assay using SYBR Green I for provirus load quantification in a murine model of AIDS 249
Effect of macrophage depletion on viral DNA rebound following antiretroviral therapy in a murine model of AIDS (MAIDS) 247
HIV-1 Tat immunization restores immune homeostasis and attacks the HAART-resistant blood HIV DNA: results of a randomized phase II exploratory clinical trial 240
2',3'-Dideoxycytidine induced drug-resistance in human cells 234
New Approach using the real-time PCR method for estimation of the toxic marine dinoflagellate Ostreopsis cf. ovata in marine environment 233
Fast and sensitive quantitative detection of HIV DNA in whole blood leucocytes by SYBR Green I real-time PCR assay 232
Fast and sensitive quantitative detection of HIV DNA in whole blood leucocytes by SYBR green I real-time PCR assay. 232
Development of a real-time PCR assay using SYBR Green I for provirus load quantification in a murine model of AIDS 232
Pharmaceutical composition or composition package containing a pyrimidine nucleoside analog and a purine nucleoside analog 225
Macrophage protection by addition of glutathione (GSH)-loaded erythrocytes to AZT and DDI in a murine AIDS model. 224
Inhibition of murine AIDS by combination of AZT and dideoxycytidine 5'-triphosphate 222
Inhibition of murine AIDS by a heterodinucleotide of azidothymidine and 9-(R)-2-(phosphonomethoxypropyl)adenine 219
Control of the HIV-1 DNA Reservoir Is Associated In Vivo and In Vitro with NKp46/NKp30 (CD335 CD337) Inducibility and Interferon Gamma Production by Transcriptionally Unique NK Cells 219
Targeting antiviral nucleotide analogues to macrophages 217
Antiretroviral effect of combined zidovudine and reduced glutathione therapy in murine AIDS. 214
Red blood cells as advanced drug delivery systems for antiviral nucleoside analogues 211
Protein degradation and apoptotic death in lymphocytes during fiv infection: activation of the ubiquitin-proteasome proteolytic system , (1999) 381-390 209
Repeated cycles of alternate administration of fludarabine and zidovudine plus didanosine inhibits murine AIDS and reduces proviral DNA content in lymph nodes to undetectable levels 208
HIV-infected long-term nonprogressors display a unique correlative pattern between the interleukin-7/interleukin-7 receptor circuit and T-cell homeostasis 206
Inhibition of murine AIDS by reduced glutathione. 204
Comparative analysis of T-cell turnover and homeostatic parameters in HIV-infected patients with discordant immune-virological responses to HAART 202
Human hexokinase type I microheterogeneity is due to different amino-terminal sequences 197
HIV-Tat immunization induces cross-clade neutralizing antibodies and CD4(+) T cell increases in antiretroviral-treated South African volunteers: a randomized phase II clinical trial 194
Targeting nucleotide dimers containing antiviral nucleosides 192
New treatment protocol including lympholytic and antiretroviral drugs to inhibit murine AIDS 191
Increased Bone Marrow Interleukin-7 (IL-7)/IL-7R Levels but Reduced IL-7 Responsiveness in HIV-Positive Patients Lacking CD4+ Gain on Antiviral Therapy 190
A comparative analysis of unintegrated HIV-1 DNA measurement as a potential biomarker of the cellular reservoir in the blood of patients controlling and non-controlling viral replication 190
Quantification of the Toxic Dinoflagellate Ostreopsis spp. by qPCR Assay in Marine Aerosol 187
Monitoring toxic Ostreopsis cf. ovata in recreational waters using a qPCR assay. 187
Efficient inhibition by Raltegravir of HIV-1 Infection in Human Primary Macrophages and in CD4+T Lymphocytes and of the cellular Apoptosis HIV-1 correlated 187
Immunophenotype and Function of CD38-Expressing CD4+ and CD8+ T Cells in HIVInfected Patients Undergoing Suppressive Combination Antiretroviral Therapy 186
Macrophage protection by nucleoside and nucleotide analogue administration 185
Continued Decay of HIV Proviral DNA Upon Vaccination With HIV-1 Tat of Subjects on Long-Term ART: An 8-Year Follow-Up Study 181
Up-regulation of the ubiquitin-conjugating and proteolytic systems in murine acquired immunodeficiency syndrome 179
Genetic diversity of the genus Ostreopsis Schmidt:phylogeographical considerations and molecularmethodology applications for field detectionin the Mediterranean Sea 177
Inhibition of murine AIDS by combination of AZT and DDCTP-loaded erythrocytes 176
Different kinetics of viral replication and DNA integration in the main HIV-1 cellular reservoirs in the presence and absence of integrase inhibitors 176
Competitive PCR for quntification of BM5d proviral DNA in mice with AIDS. 175
Synthesis and targeted delivery of an azidothymidine homodinucleotide conferring protection to macrophages against retroviral infection 173
The soluble but not mitochondrially bound hexokinase is a substrate for the ATP- and ubiquitin-dependent proteolytic system 171
GSH and analogs in antiviral therapy 171
Mitochondria as cellular hub in neonatal hypoxic-ischemic encephalopathy: identification of melatonin-responsive biomarkers predicting brain damage severity 170
Human hexokinase type I microheterogeneity is due to different amino-terminal 170
Inhibition of murine AIDS by a new azidothymidine homodinucleotide 170
Efficacy and toxicity of long-term administration of 2',3'-dideoxycytidine in the LP-BM5 murine-induced immunodeficiency model 170
Inhibition of Murine AIDS by a New Azidothymidine Homodinucleotide. 169
Molecular studies in Duchenne and Becker muscular dystrophies 168
Drug-loaded red blood cell-mediated clearance of HIV-1 macrophage reservoir by selective inhibition of STAT1 expression. 168
Effect of macrophage depletion on viral DNA rebound following antiretroviral therapy in a murine model of AIDS 167
Inhibition of HIV-1 and LP-BM5 replication in macrophages by dideoxycytidine and dideoxycytidine 5'-triphosphate 166
Metabolism, mitochondrial uptake and toxicity of 2’,3’-dideoxycytidine 166
A p12 gag gene homologue is present in the mouse genome. 166
Protein degradation and apoptotic death in lymphocytes during FIV infection: activation of the ubiquitin-proteasome proteolytic system 164
HIV-infected long-term nonprogressors display a unique correlative pattern between the interleukin-7/interleukin-7 receptor circuit and T-cell homeostasis. 164
T-Cell Dynamics and Homeostatic Pathways in HAART-Treated HIV-Infected Patients. 164
Inhibition of murine retrovirus induced immunodeficiency by nucleoside analogues and combination therapy. 164
Liposomes as carriers of the antiretroviral agent dideoxycytidine-5'-triphosphate. 163
Erythrocyte-based targeted release to macrophages of an azidothymidine homodinucleotide prevents retroviral infection 161
BIOTECNOLOGIE: APPLICAZIONI NEL SETTORE MEDICO E FARMACEUTICO 158
Macrophage protection by nucleoside and nucleotide analogue administration 158
Erythrocytes as carriers of reduced glutathione (GSH) in the treatment of retroviral infections 155
Targeting antiviral nucleotide analogues to macrophages 154
Red blood cells as carriers of drugs against retroviruses 150
Inhibition of murine AIDS by alternate administration of azidothimidine and fludarabine monofosfate. 150
Macrophage depletion by Clodronate-loaded erythrocytes 149
Molecular basis of the 2',3'-dideoxycytidine induced drug-resistance in human cells 147
Comparing Heterologous and Homologous {COVID}-19 Vaccination: A Longitudinal Study of Antibody Decay 147
Hexokinase is not ubiquitaned when mitochondrial-bound 146
New drug combinations for the treatment of murine AIDS and macrophage protection. 141
Reduction of Immune Activation and Partial Recovery of Staphylococcal Enterotoxin B-Induced Cytokine Production After Switching to an Integrase Strand Transfer Inhibitor-Containing Regimen: Results from an Observational Cohort Study 138
Role of macrophage protection in the development of murine AIDS. 136
Studio delle dinamiche di crescita di Ostreopsis cf. ovata con nuove metodologie molecolari di qrt-PCR 133
Evaluation of Two-Month Antibody Levels after Heterologous ChAdOx1-S/BNT162b2 Vaccination Compared to Homologous ChAdOx1-S or BNT162b2 Vaccination 133
Role of macrophage protection in the development of murine AIDS 131
Inhibition of murine retrovirus induced immunodeficiency by nucleoside analogues and combination therapy. 130
The inhibitory effect of ddC on HIV replication diminishes in cells that are chronically exposed to the drug 118
Red blood cells as carriers of antiviral agents 101
Red blood cells as carriers af antiviral agents 99
Persistence of Unintegrated HIV DNA Associates With Ongoing NK Cell Activation and CD34+DNAM-1brightCXCR4+ Precursor Turnover in Vertically Infected Patients Despite Successful Antiretroviral Treatment 94
External quality assessment of HIV-1 DNA quantification assays used in the clinical setting in Italy 90
Analysis of humoral and cellular immune activation up to 21 months after heterologous and homologous COVID-19 vaccination 87
New treatment protocol including Lympholitic and antiretroviral drugs to inhibit murine AIDS. 79
Rapid monitoring of SARS-CoV-2 variants of concern through high-resolution melt analysis 77
Primary HIV infection features colonic damage and neutrophil inflammation yet containment of microbial translocation 72
Melatonin Reduces Mito-Inflammation in Ischaemic Hippocampal HT22 Cells and Modulates the cGAS–STING Cytosolic DNA Sensing Pathway and FGF21 Release 72
SARS-CoV-2 RNA Detection on Environmental Surfaces in a University Setting of Central Italy 71
Totale 18.691
Categoria #
all - tutte 62.873
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 62.873


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.182 0 0 0 0 0 122 115 104 362 153 247 79
2021/20221.149 85 97 111 127 31 59 45 60 108 87 66 273
2022/20231.551 191 66 18 189 163 332 7 103 292 62 75 53
2023/2024493 42 35 38 42 34 158 14 34 2 45 3 46
2024/20251.659 89 55 334 106 59 110 215 86 186 117 191 111
2025/20262.470 377 384 613 713 369 14 0 0 0 0 0 0
Totale 18.790